Screener
Amneal Pharmaceuticals, Inc. AMRX Other — Net revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Amneal Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001723128-26-000031
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Total Specialty net revenue | 149,295 | 128,043 | 282,560 | 236,340 |
| AvKARE | ||||
| Distribution | 86,930 | 99,663 | 176,079 | 204,558 |
| Government label | 50,207 | 45,418 | 110,156 | 95,558 |
| Institutional | 12,112 | 10,132 | 21,931 | 21,141 |
| Other | 7,740 | 7,827 | 14,840 | 14,198 |
| Total AvKARE net revenue | 156,989 | 163,040 | 323,006 | 335,455 |
| Total net revenue | $796,197 | $724,508 | $1,518,716 | $1,419,928 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Amneal Pharmaceuticals, Inc.'s other — net revenue?
- Amneal Pharmaceuticals, Inc. (AMRX) reported other — net revenue of $7.74M in Q2 2026.
- How has Amneal Pharmaceuticals, Inc.'s other — net revenue changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s other — net revenue decreased by 1.1% year-over-year, from $7.83M to $7.74M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s other — net revenue?
- Over 4 years (2021 to 2025), Amneal Pharmaceuticals, Inc.'s other — net revenue has grown at a 25.2% compound annual growth rate (CAGR), from $12.54M to $30.79M.
- What does other — net revenue mean?
- This metric represents the total revenue generated from business activities, products, or services that do not fall under the company's primary reportable segments. It captures income from ancillary operations or non-core business lines that contribute to the overall top-line performance. Monitoring this figure helps investors understand the scale and growth trajectory of secondary revenue streams outside of the company's main strategic focus areas.
Ask your AI about Amneal Pharmaceuticals, Inc.'s other — net revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude